Abner Herrman & Brock LLC Gilead Sciences, Inc. Transaction History

Abner Herrman & Brock LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 10, 2020	SELL	$61.62 - $67.78 $437,994 - $481,780	-7,108 Closed	0 $0
Q3 2019 Oct 11, 2019	SELL	$62.51 - $69.0 $3,875 - $4,278	-62 Reduced 0.86%	7,108 $451,000
Q3 2018 Oct 19, 2018	SELL	$71.28 - $78.92 $142,987 - $158,313	-2,006 Reduced 21.86%	7,170 $554,000
Q2 2018 Jul 06, 2018	SELL	$64.88 - $75.68 $149,224 - $174,064	-2,300 Reduced 20.04%	9,176 $650,000
Q1 2018 Apr 06, 2018	BUY	$72.84 - $88.8 $134,025 - $163,392	1,840 Added 19.1%	11,476 $865,000
Q4 2017 Jan 05, 2018	SELL	$71.15 - $83.52 $99,183 - $116,426	-1,394 Reduced 12.64%	9,636 $690,000
Q3 2017 Oct 06, 2017	BUY	$72.11 - $85.47 $795,373 - $942,734	11,030	11,030 $894,000

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

Stay updated on Abner Herrman & Brock LLC with notifications on news.